GSK Closes China Neuroscience Center In Latest R&D Reorganization

The axe comes sooner but was not unexpected, given past controversy and a fresh direction under the leadership of GSK's new CEO Emma Walmsley who once spent years in Shanghai, where the company’s China R&D center is located.

Emma Walmsley GSK

More from China

More from Focus On Asia